41/M – Rx age 42 | CLL/Marginal Zone PB/marrow only | t(2;7); CD5+ CD23-, CD 20 ++ | 375-1500 mg/m2 Intermittent, 3 yrs | CR x 10+ years |
52/F – Rx age 52 | MCL variant PB/marrow only | t(11;14); CD5+ CD23-, CD20++ | 500– 1500 mg/m2 6 total doses | CR x 15+ years |
60/F – Rx age 60 | FL; bulky left inguinal/iliac LNs | Kappa, BCL6, BCL2– 65% of B cells; Ki67 -20% | 375– 1500 mg/m2 Induction/maint x 8 mo | CR x 6.5+ years |
58/F - (prior RX) RX w R age 64 | WM – marrow/bone/severe anemia | IgM>400; IgG 173; IgA <7 | 375-1500 mg/m2 1 year | PR/SD – no anemia, no clinical findings; SPEP stable x 13+ years |